# Idebenone to Treat Friedreich's Ataxia

> **NCT00229632** · PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 51 (actual)

## Conditions studied

- Friedreich Ataxia

## Interventions

- **DRUG:** Idebenone

## Key facts

- **NCT ID:** NCT00229632
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09-27
- **Primary completion:** 2007-12-17
- **Final completion:** 2007-12-17
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2019-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00229632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00229632, "Idebenone to Treat Friedreich's Ataxia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00229632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*